anti-4Dc antibody (Trilex)

N/A

Report date: 2025/03/17 20:00:36

Base Information

Drug Nameanti-4Dc antibody (Trilex)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLymphoma, T-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTrilex Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTrilex Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsLymphoma, T-Cell

Other Information

ATC CodeN/A
Related LinksN/A